Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynn Onstad

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Contemporary Clinical Trials|July 22, 2024
Study Protocol: Predicting the Quality of Response to Specific Treatments (PQRST) in Chronic Graft-versus-Host DiseaseBetty K Hamilton, Lynn Onstad, Paul A Carpenter, et al.
Transplantation and Cellular Therapy|March 25, 2026
Fear of cancer recurrence in hematopoietic cell transplantation survivors: fear of cancer recurrence in HCT survivorsEmily C Liang, Megan J Shen, Rachel B Salit, et al.
Radiation Research|August 3, 2006
Childhood thyroid cancer, radiation dose from Chernobyl, and dose uncertainties in Bryansk Oblast, Russia: a population-based case-control studyKenneth J Kopecky, Valery Stepanenko, Nikolai Rivkind, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 15, 2017
Success of Immunosuppressive Treatments in Patients with Chronic Graft-versus-Host DiseaseStephanie J Lee, Tam D Nguyen, Lynn Onstad, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 9, 2019
The Chronic Graft-versus-Host Disease Failure-Free Survival (cGVHD-FFS) IndexJoseph A Pidala, Betty K Hamilton, Paul J Martin, et al.
Haematologica|May 25, 2023
Patient-reported treatment response in chronic graft-<i>versus</i>-host diseaseAnnie Im, Iskra Pusic, Lynn Onstad, et al.
JAMA Dermatology|January 21, 2026
Discordance in Treatment Response Assessment Between Clinicians and Patients With Skin Chronic Graft-vs-Host DiseaseVarshini Babu, Daniel B Shin, Lynn Onstad, et al.
Blood Advances|September 17, 2021
Initial therapy for chronic graft-versus-host disease: analysis of practice variation and failure-free survivalJoseph Pidala, Lynn Onstad, Paul J Martin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2023
Targeting Hedgehog Signaling with Glasdegib in Patients with Refractory Sclerotic Chronic GVHD: A Report of Two Phase I/II TrialsEduardo Rodríguez-Arbolí, Catherine J Lee, Teresa Caballero-Velázquez, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 9, 2018
Employment, Insurance, and Financial Experiences of Patients with Chronic Graft-versus-Host Disease in North AmericaNandita Khera, Betty K Hamilton, Joseph A Pidala, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Contemporary Clinical Trials|July 22, 2024
Study Protocol: Predicting the Quality of Response to Specific Treatments (PQRST) in Chronic Graft-versus-Host DiseaseBetty K Hamilton, Lynn Onstad, Paul A Carpenter, et al.
Transplantation and Cellular Therapy|March 25, 2026
Fear of cancer recurrence in hematopoietic cell transplantation survivors: fear of cancer recurrence in HCT survivorsEmily C Liang, Megan J Shen, Rachel B Salit, et al.
Radiation Research|August 3, 2006
Childhood thyroid cancer, radiation dose from Chernobyl, and dose uncertainties in Bryansk Oblast, Russia: a population-based case-control studyKenneth J Kopecky, Valery Stepanenko, Nikolai Rivkind, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 15, 2017
Success of Immunosuppressive Treatments in Patients with Chronic Graft-versus-Host DiseaseStephanie J Lee, Tam D Nguyen, Lynn Onstad, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 9, 2019
The Chronic Graft-versus-Host Disease Failure-Free Survival (cGVHD-FFS) IndexJoseph A Pidala, Betty K Hamilton, Paul J Martin, et al.
Haematologica|May 25, 2023
Patient-reported treatment response in chronic graft-<i>versus</i>-host diseaseAnnie Im, Iskra Pusic, Lynn Onstad, et al.
JAMA Dermatology|January 21, 2026
Discordance in Treatment Response Assessment Between Clinicians and Patients With Skin Chronic Graft-vs-Host DiseaseVarshini Babu, Daniel B Shin, Lynn Onstad, et al.
Blood Advances|September 17, 2021
Initial therapy for chronic graft-versus-host disease: analysis of practice variation and failure-free survivalJoseph Pidala, Lynn Onstad, Paul J Martin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2023
Targeting Hedgehog Signaling with Glasdegib in Patients with Refractory Sclerotic Chronic GVHD: A Report of Two Phase I/II TrialsEduardo Rodríguez-Arbolí, Catherine J Lee, Teresa Caballero-Velázquez, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 9, 2018
Employment, Insurance, and Financial Experiences of Patients with Chronic Graft-versus-Host Disease in North AmericaNandita Khera, Betty K Hamilton, Joseph A Pidala, et al.
Pageof 7